Company Analysis Avantor
1. Summary
Advantages
- The stock's return over the last year (-6.93%) is higher than the sector average (-9.32%).
- The company's current efficiency (ROE=6.11%) is higher than the sector average (ROE=0.5599%)
Disadvantages
- Price (22.4 $) is higher than fair price (6.6 $)
- Dividends (0%) are below the sector average (2.38%).
- Current debt level 42.68% has increased over 5 years from 0.9567%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Avantor | Materials | Index | |
|---|---|---|---|
| 7 days | 1.9% | -4.5% | 1.6% |
| 90 days | -17.8% | -15.3% | 4.3% |
| 1 year | -6.9% | -9.3% | 27% |
AVTR vs Sector: Avantor has outperformed the "Materials" sector by 2.39% over the past year.
AVTR vs Market: Avantor has significantly underperformed the market by -33.94% over the past year.
Stable price: AVTR is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: AVTR with weekly volatility of -0.1332% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (22.4 $) is higher than the fair price (6.6 $).
Price is higher than fair: The current price (22.4 $) is 70.5% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (48.76) is higher than that of the sector as a whole (24.48).
P/E vs Market: The company's P/E (48.76) is higher than that of the market as a whole (47.37).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (2.98) is lower than that of the sector as a whole (5.66).
P/BV vs Market: The company's P/BV (2.98) is lower than that of the market as a whole (22.69).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.25) is lower than that of the sector as a whole (2.86).
P/S vs Market: The company's P/S indicator (2.25) is lower than that of the market as a whole (15.16).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (16.58) is higher than that of the sector as a whole (11.98).
EV/Ebitda vs Market: The company's EV/Ebitda (16.58) is lower than that of the market as a whole (17.77).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 35.36% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (35.36%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (479.81%).
5.4. ROE
ROE vs Sector: The company's ROE (6.11%) is higher than that of the sector as a whole (0.5599%).
ROE vs Market: The company's ROE (6.11%) is lower than that of the market as a whole (17.14%).
5.5. ROA
ROA vs Sector: The company's ROA (2.48%) is lower than that of the sector as a whole (7.13%).
ROA vs Market: The company's ROA (2.48%) is lower than that of the market as a whole (6.51%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (8.54%) is lower than that of the sector as a whole (13.16%).
ROIC vs Market: The company's ROIC (8.54%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.38%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (5.7%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Buying Exceeds insider sales by 100% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 30.07.2024 | Couturier Christophe Officer |
Purchase | 27.01 | 270 100 | 10 000 |
| 11.04.2023 | Couturier Christophe EVP, AMEA |
Sale | 21.18 | 31 728 | 1 498 |
| 23.02.2022 | Brophy Gerard EVP, Biopharma Production |
Sale | 33.79 | 103 364 | 3 059 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
